This document outlines the sale of a direct-to-consumer subscription-based health supplement brand addressing chronic bad breath through gut health solutions. Launched in 2025, the brand has achieved a substantial $945K in trailing twelve-month revenue, with a net profit of $228K and a customer base of approximately 2,250 active subscribers contributing over $100K in monthly recurring revenue. The business operates efficiently with gross margins of around 70% and a modest customer acquisition cost of $32. It's well-supported by an outsourced team that requires minimal founder involvement, making it a lean yet profitable operation. The reason for starting the business was to offer a long-term solution to the widespread problem of chronic bad breath, emphasizing the root cause—gut health—unlike other superficial remedies. The founder aims to exit in search of other endeavors, seeking an experienced buyer to further scale the brand by broadening products and stepping into new markets. The supply chain is streamlined with manufacturing managed by a reliable supplier, ensuring fast lead times and low working capital needs. Inventory is efficiently managed on a just-in-time basis, facilitating scalability without overstocking. Marketing primarily involves paid acquisition strategies, notably through Meta Ads, supplemented by a strong email marketing approach. Opportunities for growth include product line expansion, establishing an Amazon presence, engaging an existing contact list for reactivation, and exploring geographic markets like Canada, the UK, and Australia. The business is primed for growth under new ownership, equipped with transition support and a roster of virtual team members to ensure continued success. Sale inclusions encompass digital assets, subscriber lists, and operational support, positioning it as a valuable opportunity for a capable operator looking to expand in the health sector.